-transparent.png){kind=logo}
A number of recent reports have now shown that hematopoietic stem cells are present in the circulation, and these cells have the potential to restore complete hematopoiesis following marrow aplasia. Peripheral stem cells have been collected by continuous flow leukapheresis during periods of hematopoietic regeneration after 2 to 3 weeks of intensive chemotherapy. Following marrow ablative chemotherapy or chemoradiotherapy, the autologous peripheral stem cells are thawed and infused intravenously. When a sufficient stem cell dose was given, rapid neutrophil and platelet recovery has been confirmed, as compared with bone marrow transplantation. Acute leukemia, malignant lymphoma and solid tumors may benefit from this approach, and long-lasting remission or cure may result in a significant number of patients.
T Ninomiya, and
T Watanabe, and
Y Takaue
August 1995,
Health technology assessment,
T Ninomiya, and
T Watanabe, and
Y Takaue
January 1989,
Klinische Padiatrie,
T Ninomiya, and
T Watanabe, and
Y Takaue
October 1987,
Transplantation,
T Ninomiya, and
T Watanabe, and
Y Takaue
December 1990,
Zhonghua nei ke za zhi,
T Ninomiya, and
T Watanabe, and
Y Takaue
September 1997,
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
T Ninomiya, and
T Watanabe, and
Y Takaue
August 1998,
Bone marrow transplantation,
T Ninomiya, and
T Watanabe, and
Y Takaue
June 2009,
Expert review of hematology,
T Ninomiya, and
T Watanabe, and
Y Takaue
March 1995,
Nihon rinsho. Japanese journal of clinical medicine,
T Ninomiya, and
T Watanabe, and
Y Takaue
January 1999,
Bailliere's best practice & research. Clinical haematology,
T Ninomiya, and
T Watanabe, and
Y Takaue
November 1997,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
